# Modulation of Spinal GABAergic Inhibition and Mechanical Hypersensitivity following Chronic Compression of Dorsal Root Ganglion in the Rat

**Authors:** Moon Chul Lee, Taick Sang Nam, Se Jung Jung, Young S. Gwak, Joong Woo Leem

PMC · DOI: 10.1155/2015/924728 · Neural Plasticity · 2015-09-14

## TL;DR

This study explores how chronic compression of nerve clusters in rats affects pain sensitivity and spinal GABA activity over time.

## Contribution

The study reveals how spinal GABAergic inhibition dynamically modulates neuropathic pain following chronic compression of dorsal root ganglion.

## Key findings

- Early phase of CCD reduces spinal GABA-immunoreactive neurons and increases mechanical hypersensitivity.
- Spinal GABA-A and GABA-B agonists suppress early-phase hypersensitivity, while antagonists enhance late-phase recovery.
- Reduced GABAergic inhibition correlates with mechanical hypersensitivity that diminishes over time.

## Abstract

Chronic compression of dorsal root ganglion (CCD) results in neuropathic pain. We investigated the role of spinal GABA in CCD-induced pain using rats with unilateral CCD. A stereological analysis revealed that the proportion of GABA-immunoreactive neurons to total neurons at L4/5 laminae I–III on the injured side decreased in the early phase of CCD (post-CCD week 1) and then returned to the sham-control level in the late phase (post-CCD week 18). In the early phase, the rats showed an increase in both mechanical sensitivity of the hind paw and spinal WDR neuronal excitability on the injured side, and such increase was suppressed by spinally applied muscimol (GABA-A agonist, 5 nmol) and baclofen (GABA-B agonist, 25 nmol), indicating the reduced spinal GABAergic inhibition involved. In the late phase, the CCD-induced increase in mechanical sensitivity and neuronal excitability returned to pre-CCD levels, and such recovered responses were enhanced by spinally applied bicuculline (GABA-A antagonist, 15 nmol) and CGP52432 (GABA-B antagonist, 15 nmol), indicating the regained spinal GABAergic inhibition involved. In conclusion, the alteration of spinal GABAergic inhibition following CCD and leading to a gradual reduction over time of CCD-induced mechanical hypersensitivity is most likely due to changes in GABA content in spinal GABA neurons.

## Linked entities

- **Chemicals:** GABA (PubChem CID 119), muscimol (PubChem CID 4266), baclofen (PubChem CID 2284), bicuculline (PubChem CID 2376), CGP52432 (PubChem CID 132252)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Igh-V7183 (immunoglobulin heavy chain (V7183 family)) [NCBI Gene 16059] {aka B9-scFv, IgG, IgH, IgVH1(VSG), VH7183, VI24H}, Rbfox3 (RNA binding fox-1 homolog 3) [NCBI Gene 287847] {aka Hrnbp3, Neun, RGD1560070}, Prkaca (protein kinase cAMP-activated catalytic subunit alpha) [NCBI Gene 25636] {aka Cs-PKA, PKCA1}, F2rl1 (F2R like trypsin receptor 1) [NCBI Gene 116677] {aka Par-2, Par2}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 60463], Rbfox3 (RNA binding protein, fox-1 homolog (C. elegans) 3) [NCBI Gene 52897] {aka Fox-3, Hrnbp3, NeuN, Neuna60}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 24770] {aka MCP-1, MCP1, Scya2, Sigje}, Gad2 (glutamate decarboxylase 2) [NCBI Gene 24380] {aka gad65}
- **Diseases:** CCD (MESH:D020512), spinal nerve ligation injury (MESH:D061227), Hypersensitivity (MESH:D004342), tumors (MESH:D009369), nerve injury (MESH:D000080902), spinal disc herniation (MESH:D007405), Neuropathic pain (MESH:D009437), intervertebral foramen stenosis (MESH:D003251), sciatic nerve transaction injury (MESH:D020426), neuronal hyperexcitability (MESH:D009410), peripheral nerve injury (MESH:D059348), allodynia (MESH:D006930), spinal abnormalities (MESH:D016472), inflammatory (MESH:D007249), pain (MESH:D010146), spinal cord (MESH:D013118), Compression of Dorsal Root Ganglion (MESH:D011843), spinal infections (MESH:D007239), chronic low back pain (MESH:D017116), spinal cord injury (MESH:D013119), spinal stenosis (MESH:D013130),  (MESH:D013117)
- **Chemicals:** CGP52432 (MESH:C083008), sodium chloride (MESH:D012965), DAB (MESH:C000469), H2O2 (MESH:D006861), enflurane (MESH:D004737), water (MESH:D014867), SP15-100 (-), bicuculline (MESH:D001640), mineral oil (MESH:D008899), Toluene (MESH:D014050), methanol (MESH:D000432), stainless steel (MESH:D013193), potassium (MESH:D011188), glutamate (MESH:D018698), sodium metabisulfite (MESH:C005200), oxygen (MESH:D010100), baclofen (MESH:D001418), urethane (MESH:D014520), ethyl alcohol (MESH:D000431), CO2 (MESH:D002245), sodium (MESH:D012964), xylene (MESH:D014992), carbon (MESH:D002244), bicuculline methobromide (MESH:C036615), oil (MESH:D009821), glutaraldehyde (MESH:D005976), muscimol (MESH:D009118), GABA (MESH:D005680),  (MESH:D018756),  (MESH:D001596),  (MESH:D010721),  (MESH:D058788),  (MESH:D058787)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4584224/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4584224/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC4584224/full.md

---
Source: https://tomesphere.com/paper/PMC4584224